It hasn’t gone away: the problem of glucocorticoid use in lupus remains
- 24 December 2016
- journal article
- review article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 56, i114-i122
- https://doi.org/10.1093/rheumatology/kew406
Abstract
The treatment of SLE remains complex, and management is constrained by a lack of safe, effective, targeted therapies. Physicians, also, are constrained by a lack of evidence-based approaches with existing agents, including glucocorticoids, utilized in the majority of patients. While Cushingoid side effects of glucocorticoids are widely recognized, emerging literature now suggests that glucocorticoid use actually contributes to harmful outcomes in SLE, over and above these effects. These studies provide a compelling case for a re-evaluation of the long-term use of glucocorticoids in SLE, focusing on minimizing glucocorticoid exposure as part of the strategy to improve long-term outcomes. In this article, we review the evidence for the harmful effects of glucocorticoids in SLE, and propose therapeutic options that reduce reliance on glucocorticoids. We propose that it is time for the lupus community to have a louder conversation about glucocorticoid use, and for any residual complacency about their risk-benefit ratio to be banished.Keywords
This publication has 76 references indexed in Scilit:
- Systemic lupus erythematosus: which drugs and when?International Journal of Clinical Rheumatology, 2014
- Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception CohortAnnals Of The Rheumatic Diseases, 2014
- Treat-to-target in systemic lupus erythematosus: recommendations from an international task forceAnnals Of The Rheumatic Diseases, 2014
- Global Trend of Survival and Damage of Systemic Lupus Erythematosus: Meta-Analysis and Meta-Regression of Observational Studies from the 1950s to 2000sSeminars in Arthritis and Rheumatism, 2012
- Disease activity and damage accrual during the early disease course in a multinational inception cohort of patients with systemic lupus erythematosusLupus, 2010
- Damage and mortality in a group of British patients with systemic lupus erythematosus followed up for over 10 yearsRheumatology, 2009
- Changing Patterns in Mortality and Disease Outcomes for Patients with Systemic Lupus ErythematosusThe Journal of Rheumatology, 2008
- Mortality in systemic lupus erythematosusArthritis & Rheumatism, 2006
- Systemic lupus erythematosus in three ethnic groups: IX. Differences in damage accrualArthritis & Rheumatism, 2001
- Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992Arthritis & Rheumatism, 1999